TR200003143A2 - Sodyum-hidrojen değiştirici tip 1 engelleyici hazırlama için yöntem - Google Patents

Sodyum-hidrojen değiştirici tip 1 engelleyici hazırlama için yöntem

Info

Publication number
TR200003143A2
TR200003143A2 TR2000/03143A TR200003143A TR200003143A2 TR 200003143 A2 TR200003143 A2 TR 200003143A2 TR 2000/03143 A TR2000/03143 A TR 2000/03143A TR 200003143 A TR200003143 A TR 200003143A TR 200003143 A2 TR200003143 A2 TR 200003143A2
Authority
TR
Turkey
Prior art keywords
blocker
exchanger type
preparing sodium
hydrogen exchanger
preparing
Prior art date
Application number
TR2000/03143A
Other languages
English (en)
Turkish (tr)
Inventor
Jacqueline Tom Norma
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200003143A2 publication Critical patent/TR200003143A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/10Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR2000/03143A 1999-10-29 2000-10-26 Sodyum-hidrojen değiştirici tip 1 engelleyici hazırlama için yöntem TR200003143A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237799P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
TR200003143A2 true TR200003143A2 (tr) 2001-05-21

Family

ID=22585372

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03143A TR200003143A2 (tr) 1999-10-29 2000-10-26 Sodyum-hidrojen değiştirici tip 1 engelleyici hazırlama için yöntem

Country Status (19)

Country Link
US (1) US6441176B1 (https=)
EP (1) EP1101763A3 (https=)
JP (1) JP3342475B2 (https=)
KR (2) KR100449595B1 (https=)
CN (1) CN1146557C (https=)
AR (1) AR029188A1 (https=)
AU (1) AU779106B2 (https=)
BR (1) BR0005122A (https=)
CA (1) CA2324640A1 (https=)
CZ (1) CZ20004018A3 (https=)
HU (1) HUP0004187A2 (https=)
ID (1) ID27904A (https=)
IL (1) IL139198A0 (https=)
PL (1) PL343542A1 (https=)
RU (1) RU2190605C2 (https=)
TR (1) TR200003143A2 (https=)
TW (1) TWI221152B (https=)
YU (1) YU62900A (https=)
ZA (1) ZA200006007B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852733B2 (en) 2000-04-28 2005-02-08 Pfizer Inc. Sodium-hydrogen exchanger type 1 inhibitor
CN1479737A (zh) * 2001-01-31 2004-03-03 �Ʒ� 钠-质子交换蛋白1型抑制剂的乙醇盐
EP1456181A1 (en) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028381A (en) * 1975-05-05 1977-06-07 Ciba-Geigy Corporation Pyrazolobenzazepines
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
RU2009129C1 (ru) * 1991-12-16 1994-03-15 Центр по химии лекарственных средств Арилгидразоны 5,6,7,8-тетрагидрохинолиндионы-2,5, обладающие кардиотонической активностью
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
PT1056729E (pt) 1998-02-27 2005-04-29 Pfizer Prod Inc Derivados de n-[ciclo di- ou tri-aza di-insaturado de cinco membros substituido) carbonil] guanidina para o tratamento de isquemia
UA72002C2 (en) 1999-10-29 2005-01-17 Pfizer Prod Inc Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage

Also Published As

Publication number Publication date
KR100443851B1 (ko) 2004-08-11
CZ20004018A3 (cs) 2002-04-17
HUP0004187A2 (hu) 2002-11-28
RU2190605C2 (ru) 2002-10-10
BR0005122A (pt) 2001-06-19
KR20030061767A (ko) 2003-07-22
KR100449595B1 (ko) 2004-09-21
AU779106B2 (en) 2005-01-06
YU62900A (sh) 2003-08-29
AR029188A1 (es) 2003-06-18
US6441176B1 (en) 2002-08-27
PL343542A1 (en) 2001-05-07
CN1295070A (zh) 2001-05-16
HK1036057A1 (en) 2003-07-10
EP1101763A2 (en) 2001-05-23
JP3342475B2 (ja) 2002-11-11
CN1146557C (zh) 2004-04-21
ID27904A (id) 2001-05-03
HU0004187D0 (https=) 2001-01-29
EP1101763A3 (en) 2002-04-24
CA2324640A1 (en) 2001-04-29
ZA200006007B (en) 2002-04-26
JP2001158784A (ja) 2001-06-12
KR20010060211A (ko) 2001-07-06
IL139198A0 (en) 2001-11-25
TWI221152B (en) 2004-09-21
AU6133300A (en) 2001-05-03

Similar Documents

Publication Publication Date Title
ATE314364T1 (de) Heterocyclische natrium/proton- austauschinhibitoren und verfahren
ATE284853T1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
DE69934358D1 (de) Verfahren zum Auswuchten asymmetrischer chirurgischer Ultraschallklingen
ITMI991608A0 (it) Sonda elettrochirurgica per il trattamento di tumori mediante radiofre quenza
NO20005454L (no) Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmåte for fremstilling derav
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
DE69903973D1 (de) Wiedergabesteuerung in form eines ablatierten lasermerkmals
HUP0103093A3 (en) Quinolones used as mrs inhibitors and bactericides and process for their preparation
NO20005264L (no) Heterocyklisk substituerte amider, deres fremstilling og anvendelse
DE3874019D1 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
AU2002234154A1 (en) Method and apparatus for improving the efficiency of cache memories using stored activity measures
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
FI955661L (fi) Substituoidut beta-aryyli- ja beta-heteroaryyli-alfa-syanoakryyliamidijohdannaiset tyrosiinikinaasi-inhibiittoreina
TR200003143A2 (tr) Sodyum-hidrojen değiştirici tip 1 engelleyici hazırlama için yöntem
DE50108855D1 (de) Anordnung zum kühlen von elektrischen baugruppen sowie teile davon
ECSP034634A (es) Inhibidores de la farnesil transferasa
DE59812770D1 (de) Gegenstand und verfahren zur energiespeicherung in form thermischer energie mittels hochtemperatur-akkumulatoren
IT1318507B1 (it) Uso di derivati (per)fluoropolieterei nel trattamento di substrati abassa energia superficiale.
DE60023554D1 (de) Verfahren zum verbessern der weichheit und vermindern des knitterns von gewebe
DK1216253T3 (da) Fremgangsmåde til fremstilling af methylendiphosphonsyrer og salte deraf
ATE392413T1 (de) Verfahren zur herstellung von beta-alaninamiden
AP2002002651A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
DE60117783D1 (de) Naphthamidin-urokinasinhibitoren
ATE395102T1 (de) In-vitro-synchronisation der kern- und zytoplasma-reifung von oozyten mit addition und entfernung von phosphodiesterase-hemmer typ 3